[Prostatic cancer in the young adult]

Prog Urol. 2003 Apr;13(2):313-5.
[Article in French]

Abstract

Prostatic carcinoma is exceptional in young adults before the age of 30. It is often diagnosed at a late, clinically advanced stage with a poorly differentiated histological type. Treatment is usually palliative and the prognosis is very poor with a mean survival of 6 months. The authors report a new case in a 25-year-old patient with locally advanced poorly differentiated prostatic carcinoma and a Gleason score of 10 treated by endocrine therapy, radiotherapy and chemotherapy with a good clinical and radiological course with a follow-up of two years.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / radiotherapy
  • Adult
  • Androgen Antagonists
  • Combined Modality Therapy
  • Estramustine / therapeutic use
  • Humans
  • Male
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / radiotherapy
  • Radiotherapy Dosage
  • Treatment Outcome

Substances

  • Androgen Antagonists
  • Estramustine